High Tower Advisors, LLC Exact Sciences Corp Call Options Transaction History

High Tower Advisors, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$42.43 - $70.83 $12,729 - $21,249	300 New	300 $20,000
Q1 2022 May 12, 2022	BUY	$57.56 - $82.54 $172 - $247	3 Added 100.0%	6 $2,000
Q4 2020 Feb 10, 2021	SELL	$99.61 - $142.12 $19,623 - $27,997	-197 Reduced 98.5%	3 $4,000
Q2 2020 Aug 10, 2020	SELL	$55.75 - $92.75 $27,875 - $46,375	-500 Reduced 71.43%	200 $0
Q1 2020 May 21, 2020	BUY	$37.9 - $104.44 $15,160 - $41,776	400 Added 133.33%	700 $2,000
Q3 2019 Nov 12, 2019	BUY	$90.37 - $122.49 $18,074 - $24,498	200 Added 200.0%	300 $0
Q1 2019 May 15, 2019	SELL	$61.98 - $96.5 $6,198 - $9,650	-100 Reduced 50.0%	100 $1,000
Q4 2017 Feb 14, 2018	BUY	$46.49 - $60.51 $4,649 - $6,051	100 Added 100.0%	200 $1,000
Q2 2017 Aug 14, 2017	BUY	N/A	100	100 $2,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $9.93B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.